HomeLifestyleRetailJohnson & Johnson (JNJ) Earnings Prove The Free Cash Is Flowing

Johnson & Johnson (JNJ) Earnings Prove The Free Cash Is Flowing

Healthy free cash flow has enabled Johnson & Johnson (JNJ) to increase its dividend over the past half century, notes Lee Bohl. He and Damien Conover discuss takeaways from JNJ earnings. JNJ's 1Q worldwide pharmaceutical sales came in at $13.41B and its 1Q revenue came in at $24.75B versus an estimated $23.57B. They also go over other stocks to keep on your radar. Tune in to find out more about the stock market today.

Trading 360

18 Apr 2023

SHARE

ON AIR
4:00 pm
Trading 360
replay
12:00 am
Fast Market
REPLAY
1:00 am
Trading 360
REPLAY
2:00 am
Next Gen Investing
REPLAY
education
3:00 am
Your First Trade
REPLAY
3:30 am
Trading 360
REPLAY
4:30 am
Next Gen Investing
REPLAY
education
5:30 am
Your First Trade
REPLAY
6:00 am
Fast Market
REPLAY
7:00 am
Futures
8:00 am
Morning Trade Live
10:00 am
Trading 360
11:00 am
Fast Market
12:00 pm
Next Gen Investing
1:00 pm
The Watch List
2:00 pm
Market On Close
education
3:30 pm
Your First Trade
ON AIR
4:00 pm
Trading 360
REPLAY
5:00 pm
Fast Market
REPLAY
6:00 pm
Next Gen Investing
REPLAY
education
7:00 pm
Your First Trade
REPLAY
7:30 pm
Trading 360
REPLAY
8:30 pm
Fast Market
REPLAY
9:30 pm
Next Gen Investing
REPLAY
education
10:30 pm
Your First Trade
REPLAY
11:00 pm
Trading 360
REPLAY

Get the Market Minute

Daily insights for every investor

coming soon

We are now

coming soon

We are now